US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist
  • 1.620
  • +0.370+29.60%
Close Dec 24 13:00 ET
66.56MMarket Cap-5.40P/E (TTM)

About Anebulo Pharmaceuticals Company

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.

Company Profile

SymbolANEB
Company NameAnebulo Pharmaceuticals
Listing DateMay 7, 2021
Issue Price7.00
Founded2020
CEOMr. Richard Anthony Cunningham
MarketNASDAQ
Employees3
Fiscal Year Ends06-30
Address1017 Ranch Road 620 South,Suite 107
CityLakeway
ProvinceTexas
CountryUnited States of America
Zip Code78734
Phone1-512-598-0931
Websitehttp://www.anebulo.com

Company Executives

  • Name
  • Position
  • Salary
  • Richard Anthony Cunningham
  • Chief Executive Officer and Director
  • --
  • Dr. Kenneth C. Cundy,PhD
  • Chief Scientific Officer
  • 495.63K
  • Daniel V. George
  • Part Time Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Joseph F. Lawler, M.D.,PhD
  • Chairman of the Board
  • 11.00K
  • Areta Kupchyk
  • Independent Director
  • 11.00K
  • Dr. Kenneth Lin, M.D.
  • Independent Director
  • 1.00K
  • Jason M. Aryeh
  • Independent Director
  • 21.00K
  • Bimal R. Shah
  • Independent Director
  • --
  • Aron R. English
  • Independent Director
  • 1.00K
  • Dr. Nathaniel Calloway, PhD
  • Independent Director
  • 79.75K
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-2.53%